万达信息所属申万行业为：计算机-IT服务Ⅱ-IT服务Ⅲ。所属概念板块包括：家庭医生概念、电子身份 证、财税信息化、互联医疗、华为盘古等。 截至9月19日，万达信息股东户数5.84万，较上期减少1.38%；人均流通股24636股，较上期增加1.40%。 2025年1月-6月，万达信息实现营业收入9.33亿元，同比增长1.09%；归母净利润-2.99亿元，同比增长 18.20%。 10月9日，万达信息盘中上涨2.17%，截至14:24，报7.05元/股，成交1.23亿元，换手率1.24%，总市值 101.56亿元。 资金流向方面，主力资金净流出509.74万元，特大单买入102.43万元，占比0.83%，卖出675.50万元，占 比5.47%；大单买入3165.07万元，占比25.65%，卖出3101.75万元，占比25.14%。 万达信息今年以来股价跌11.21%，近5个交易日涨0.00%，近20日跌6.62%，近60日跌5.62%。 资料显示，万达信息股份有限公司位于上海市联航路1518号,上海市北京西路968号33楼，成立日期1995 年11月9日，上市日期2011年1月25日，公司主营业务涉及以公共事务为 ...

10月9日，卫宁健康盘中上涨2.07%，截至13:38，报9.39元/股，成交3.23亿元，换手率1.83%，总市值 207.94亿元。 卫宁健康所属申万行业为：计算机-软件开发-垂直应用软件。所属概念板块包括：家庭医生概念、互联 医疗、DRG概念、智慧医疗、证金汇金等。 截至9月19日，卫宁健康股东户数11.78万，较上期减少0.53%；人均流通股16244股，较上期增加 0.53%。2025年1月-6月，卫宁健康实现营业收入8.39亿元，同比减少31.43%；归母净利润-1.18亿元，同 比减少491.04%。 分红方面，卫宁健康A股上市后累计派现4.55亿元。近三年，累计派现9722.63万元。 机构持仓方面，截止2025年6月30日，卫宁健康十大流通股东中，华宝中证医疗ETF（512170）位居第 三大流通股东，持股5877.33万股，相比上期增加175.06万股。易方达创业板ETF（159915）位居第四大 流通股东，持股4526.36万股，相比上期减少65.23万股。招商优势企业混合A（217021）位居第十大流 通股东，持股2100.00万股，为新进股东。香港中央结算有限公司退出十大流通股东之列 ...

Core Viewpoint - China Ping An's stock price has shown a mixed performance in recent months, with a year-to-date increase of 10.35% but a decline over the last 20 and 60 days, indicating potential volatility in the market [1]. Group 1: Stock Performance - As of September 29, China Ping An's stock price rose by 2.01% to 56.33 CNY per share, with a trading volume of 2.369 billion CNY and a turnover rate of 0.40% [1]. - The company has experienced a net inflow of 196 million CNY from major funds, with significant buying activity from large orders [1]. - Year-to-date, the stock has increased by 10.35%, with a 2.14% rise over the last five trading days, but has seen declines of 3.73% over the last 20 days and 0.18% over the last 60 days [1]. Group 2: Financial Performance - For the first half of 2025, China Ping An reported a net profit of 68.047 billion CNY, a year-on-year decrease of 8.81% [2]. - The company has distributed a total of 374.702 billion CNY in dividends since its A-share listing, with 133.997 billion CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of June 30, 2025, China Ping An had 720,900 shareholders, a decrease of 9.74% from the previous period [2]. - The largest shareholder, Hong Kong Central Clearing Limited, holds 639 million shares, a reduction of 31.7802 million shares from the previous period [3].

Group 1 - The core viewpoint of the news is that China Pacific Insurance (China Taibao) has shown a mixed performance in its stock price, with a year-to-date increase of 8.82% but a recent decline over the past 20 days [1][2] - As of September 29, the stock price reached 35.91 CNY per share, with a market capitalization of 345.466 billion CNY and a trading volume of 10.16 billion CNY [1] - The company has experienced a net inflow of main funds amounting to 58.2254 million CNY, with significant buying and selling activities from large orders [1] Group 2 - China Pacific Insurance was established on May 13, 1991, and listed on December 25, 2007, operating primarily in life and property insurance through its subsidiaries [2] - The revenue composition of the company includes 50.17% from property insurance, 47.56% from life and health insurance, and 0.92% from asset management [2] - As of June 30, 2025, the company reported a net profit of 27.885 billion CNY, reflecting a year-on-year growth of 10.95% [2] Group 3 - Since its A-share listing, China Pacific Insurance has distributed a total of 119.281 billion CNY in dividends, with 30.015 billion CNY distributed over the past three years [3] - As of June 30, 2025, the number of shareholders decreased by 23.33%, while the average circulating shares per person increased by 31.77% [2][3] - Hong Kong Central Clearing Limited is the seventh-largest circulating shareholder, holding 219 million shares, a decrease of 33.3827 million shares from the previous period [3]

Core Viewpoint - The stock of Weining Health has shown fluctuations in recent trading sessions, with a notable increase of 2.05% on September 24, 2023, while the company faces a significant decline in revenue and profit for the first half of 2025 [1][2]. Group 1: Stock Performance - As of September 24, 2023, Weining Health's stock price reached 8.96 CNY per share, with a market capitalization of 19.836 billion CNY [1]. - The stock has increased by 25.40% year-to-date, but has seen declines of 4.38% over the last five trading days, 15.39% over the last twenty days, and 10.22% over the last sixty days [1]. Group 2: Financial Performance - For the first half of 2025, Weining Health reported a revenue of 839 million CNY, a decrease of 31.43% year-on-year, and a net profit of -118 million CNY, representing a decline of 491.04% [2]. - The company has distributed a total of 455 million CNY in dividends since its A-share listing, with 97.226 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 19, 2023, the number of Weining Health's shareholders was 117,800, a decrease of 0.53% from the previous period, while the average number of circulating shares per person increased by 0.53% to 16,244 shares [2]. - The top three circulating shareholders include Huabao Zhongzheng Medical ETF, which increased its holdings by 1.7506 million shares, and Yifangda Growth Enterprise ETF, which decreased its holdings by 652,300 shares [3].

9月23日，健之佳盘中下跌2.05%，截至09:59，报20.59元/股，成交1205.59万元，换手率0.38%，总市值 31.82亿元。 截至6月30日，健之佳股东户数1.51万，较上期减少12.99%；人均流通股10236股，较上期增加26.21%。 2025年1月-6月，健之佳实现营业收入44.57亿元，同比减少0.64%；归母净利润7237.82万元，同比增长 15.11%。 资料显示，健之佳医药连锁集团股份有限公司位于云南省昆明市盘龙区联盟街道旗营街10号，成立日期 2004年9月27日，上市日期2020年12月1日，公司主营业务涉及药品、保健食品、个人护理品、家庭健康 用品、便利食品、日用消耗品等健康产品的连锁零售业务,并提供相关专业服务。主营业务收入构成 为：处方、非处方合计(中西成药)72.60%，其中:非处方药39.64%，其中:处方药32.96%，医疗器械 7.44%，其他(补充)5.52%，生活便利品5.05%，保健食品4.84%，中药材3.28%，个人护理品1.18%，体 检服务0.09%。 （000727）位居第五大流通股东，持股710.00万股，相比上期减少29.48万股。广发创 ...

Core Viewpoint - Meinian Health's stock price has shown fluctuations, with a year-to-date increase of 12.52% but a recent decline of 2.65% over the last five trading days, indicating volatility in investor sentiment [2]. Financial Performance - For the first half of 2025, Meinian Health reported a revenue of 4.109 billion yuan, a year-on-year decrease of 2.28%, and a net profit attributable to shareholders of -221 million yuan, down 2.59% year-on-year [2]. - Cumulative cash dividends since the company's A-share listing amount to 634 million yuan, with 127 million yuan distributed over the past three years [3]. Stock Market Activity - As of September 18, Meinian Health's stock price was 5.15 yuan per share, with a market capitalization of 20.158 billion yuan. The stock experienced a net outflow of 53.52 million yuan in principal funds [1]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on February 19, where it recorded a net buy of -155 million yuan [2]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 8.95% to 172,400, while the average circulating shares per person increased by 9.87% to 22,471 shares [2]. - The top ten circulating shareholders include Huabao Zhongzheng Medical ETF, which increased its holdings by 1.9034 million shares, and a new entry,招商优势企业混合A, holding 60 million shares [3].

Core Viewpoint - China Pacific Insurance (Group) Co., Ltd. has experienced a decline in stock price recently, with significant net outflows of funds, despite a year-to-date increase in stock price [1][2]. Financial Performance - As of June 30, 2025, China Pacific Insurance reported a net profit of 27.885 billion yuan, representing a year-on-year growth of 10.95% [2]. - The company has a cumulative dividend payout of 119.281 billion yuan since its A-share listing, with 30.015 billion yuan paid out in the last three years [3]. Stock Market Activity - On September 18, 2023, the stock price of China Pacific Insurance fell by 2.01%, closing at 35.18 yuan per share, with a trading volume of 1.221 billion yuan and a turnover rate of 0.50% [1]. - The stock has increased by 6.61% year-to-date but has seen declines of 7.76% over the past five trading days, 11.83% over the past 20 days, and 3.77% over the past 60 days [1]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 23.33% to 87,600, while the average circulating shares per person increased by 31.77% to 81,698 shares [2]. - Hong Kong Central Clearing Limited is the seventh-largest circulating shareholder, holding 219 million shares, a decrease of 33.3827 million shares from the previous period [3]. Business Overview - China Pacific Insurance operates as a comprehensive insurance group, primarily through its subsidiaries, providing life and property insurance products and services [2]. - The revenue composition includes 50.17% from property insurance, 47.56% from life and health insurance, 1.35% from other and offsetting items, and 0.92% from asset management [2]. Industry Classification - The company is classified under the non-banking financial sector, specifically in the insurance industry [2]. - It is associated with various concept sectors, including family doctor concept, low price-to-earnings ratio, and state-owned enterprises [2].

Group 1 - The core viewpoint of the news is that China Pacific Insurance (China Taibao) has experienced a decline in stock price and significant net outflow of funds, indicating potential market concerns [1] - As of September 16, the stock price of China Taibao was reported at 36.26 yuan per share, with a market capitalization of 348.83 billion yuan [1] - Year-to-date, the stock price has increased by 9.88%, but it has seen a decline of 3.18% in the last five trading days and 7.19% in the last twenty days [1] Group 2 - China Taibao is a comprehensive insurance group established on May 13, 1991, and listed on December 25, 2007, with its main business involving life and property insurance through its subsidiaries [2] - The revenue composition of China Taibao includes 50.17% from property insurance, 47.56% from life and health insurance, and 0.92% from asset management [2] - As of June 30, the number of shareholders was 87,600, a decrease of 23.33% from the previous period, while the average circulating shares per person increased by 31.77% [2] Group 3 - China Taibao has distributed a total of 119.28 billion yuan in dividends since its A-share listing, with 30.02 billion yuan distributed in the last three years [3] - As of June 30, 2025, Hong Kong Central Clearing Limited was the seventh largest circulating shareholder, holding 219 million shares, a decrease of 33.38 million shares from the previous period [3]

Core Viewpoint - JiuYuan YinHai's stock price has shown fluctuations, with a recent decline of 2.12% and a year-to-date increase of 10.72%, indicating volatility in market performance [1][2]. Financial Performance - For the first half of 2025, JiuYuan YinHai reported a revenue of 439 million yuan, representing a year-on-year growth of 11.33%, and a net profit attributable to shareholders of 29.95 million yuan, which is a significant increase of 166.63% compared to the previous year [2]. - Cumulative cash dividends since the A-share listing amount to 472 million yuan, with 151 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2025, the number of shareholders increased to 58,300, up by 7.18%, while the average circulating shares per person decreased by 6.70% to 6,935 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 4.6232 million shares, an increase of 910,200 shares from the previous period, and Southern CSI 1000 ETF, holding 2.6339 million shares, up by 489,700 shares [3]. Business Overview - JiuYuan YinHai, established on November 24, 2008, and listed on December 31, 2015, focuses on software products, operation services, and system integration in the field of social security and human resources [1]. - The company's revenue composition includes 49.40% from operation services, 34.76% from software, and 15.60% from system integration [1].